A 2012 in Reproductive Toxicology by L.E. Grzeskowiak at a team from University of South Australia (Adelaide) titled “Long term impact of prenatal exposure to SSRIs on growth and body weight in childhood: evidence from animal and human studies.” explores the link between a baby’s exposure to maternal selective serotonin reuptake inhibitor drugs (SSRIs) and adverse birth outcomes.
Here is the abstract for that article:
“Prenatal exposure to SSRIs has the potential to alter fetal 5-HT signalling during critical periods of development: the long-term consequences of which have not been well studied. Of particular interest are the potential long-term effects of prenatal SSRI exposure on growth and body weight in later life, given the role of the serotonergic system in regulating food intake and body weight. Animal studies demonstrate that changes in 5-HT homeostasis during critical periods of fetal development can lead to sex-specific molecular and functional alterations in the serotonergic and HPA systems, leading to an increased risk of overweight in male, but not female, offspring in later life. This review highlights the evidence and the need for studies in humans to determine whether prenatal SSRI exposure is associated with alterations in child growth and body weight and the importance of delineating these effects from those of the underlying maternal illness.” (emphasis added)
Since thousands of expecting mothers around the world use SSRIs in pregnancy each year unaware of the risks for adverse birth outcomes, SSRI birth defect lawsuits have been filed in droves.
As such, If you or a loved one used SSRIs and gave birth to a child who faced adverse birth outcomes or had a birth defect, you may be entitled to significant financial compensation. For a free, no-obligation case consultation, contact our team of SSRI birth defect lawyers at the information provided below. We have the compassion, experience, and resources required to win the justice you deserve. Call today and see how we can help.
(855) 452 – 5529